Preparation of Ketoconazole-Loaded Nanoemulsions for Ophthalmic Delivery: Characterization and in-vitro Antifungal Activity Evaluation

IF 0.3 Q4 PHARMACOLOGY & PHARMACY Current Drug Therapy Pub Date : 2023-08-04 DOI:10.2174/1574885518666230804120659
Mohammad Mehdi Mahboobian, Negin Azadi, Shabnam Pourmoslemi
{"title":"Preparation of Ketoconazole-Loaded Nanoemulsions for Ophthalmic Delivery: Characterization and in-vitro Antifungal Activity Evaluation","authors":"Mohammad Mehdi Mahboobian, Negin Azadi, Shabnam Pourmoslemi","doi":"10.2174/1574885518666230804120659","DOIUrl":null,"url":null,"abstract":"\n\nNanoemulsions (N.E.s) capable of ocular bioavailability elevation can be used for poor water-soluble drugs such as ketoconazole (K.Z.). The current investigation was designed for the purpose of overcoming this issue by developing K.Z. containing N.E.s for ophthalmic drug delivery with appropriate therapeutic efficiency.\n\n\n\nThe preparation of ketoconazole N.E.s was performed by the low-energy technique. According to the phase diagram, three stable formulations were selected for more physicochemical analyses, including particle size, polydispersity index, pH, refractive index, osmolality, and viscosity. Finally, drug release patterns and in-vitro antifungal activity were assessed for the final selected formulation.\n\n\n\nThe developed N.E. formulations with droplet sizes less than 20nm showed appropriate physicochemical characteristics for ocular delivery. The selected formulation released 100% of the encapsulated drug during 24 h. Moreover, antifungal assessments showed that prepared N.E. had acceptable in vitro antifungal activity.\n\n\n\nBased on our findings, it can be concluded that N.E.s could be applied as effective carriers for the ophthalmic delivery of ketoconazole.\n","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574885518666230804120659","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Nanoemulsions (N.E.s) capable of ocular bioavailability elevation can be used for poor water-soluble drugs such as ketoconazole (K.Z.). The current investigation was designed for the purpose of overcoming this issue by developing K.Z. containing N.E.s for ophthalmic drug delivery with appropriate therapeutic efficiency. The preparation of ketoconazole N.E.s was performed by the low-energy technique. According to the phase diagram, three stable formulations were selected for more physicochemical analyses, including particle size, polydispersity index, pH, refractive index, osmolality, and viscosity. Finally, drug release patterns and in-vitro antifungal activity were assessed for the final selected formulation. The developed N.E. formulations with droplet sizes less than 20nm showed appropriate physicochemical characteristics for ocular delivery. The selected formulation released 100% of the encapsulated drug during 24 h. Moreover, antifungal assessments showed that prepared N.E. had acceptable in vitro antifungal activity. Based on our findings, it can be concluded that N.E.s could be applied as effective carriers for the ophthalmic delivery of ketoconazole.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
酮康唑负载纳米眼科乳剂的制备、表征及体外抗菌活性评价
能够提高眼部生物利用度的纳米乳液(N.E.s)可用于水溶性差的药物,如酮康唑(K.Z.)。目前的研究旨在通过开发具有适当治疗效率的含K.Z.的N.E.s用于眼科药物递送来克服这一问题。酮康唑N.E.的制备采用低能耗技术。根据相图,选择了三种稳定的配方进行更多的物理化学分析,包括粒度、多分散指数、pH、折射率、渗透压和粘度。最后,对最终选择的制剂的药物释放模式和体外抗真菌活性进行了评估。所开发的液滴尺寸小于20nm的N.E.制剂显示出适合眼部递送的物理化学特性。所选制剂在24小时内释放出100%的包封药物。此外,抗真菌评估表明,制备的N.E.具有可接受的体外抗真菌活性。根据我们的研究结果,可以得出结论,N.E.可以作为酮康唑眼科给药的有效载体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Drug Therapy
Current Drug Therapy PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
50
期刊介绍: Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.
期刊最新文献
Pharmacological Investigation of Anticonvulsant Effect of Artemisia Vulgaris on Pentylenetetrazole-Induced Epileptic Seizures in Zebrafish Experimental Model Evaluation of Phytochemicals, Antioxidants, and Antidiabetic Activity of Nitophyllum marginale by Using Analytical Approaches Evaluation of Clozapine-induced Toxicities in Psychic Patients in Mental Health Care Hospitals in the Southern Region of the Saudi Arabia Kingdom Investigation of Nosocomial Urinary Tract Infections Post Transplantation, Main Pathogens, and Sensitivity Tests Inclusive Exploration of Harmonizing and Alternative Treatments for Hypothyroidism
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1